Epstein Secrets

ing on `unsustainable drug prices' concludes — Hybrid hearing on `Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM * Tom Lantos Human

ctor Matt Gorham will offer opening remarks on the new strategy, followed by an in-depth panel conversation moderated by McCrary Institute Director Frank Cilluffo and an audience question-and-answer session. The panel will consist of Gorham; Tonya Ugoretz, FBI deputy assistant director; and Clyde Wallace, FBI

ing on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

ctor Matt Gorham will offer opening remarks on the new strategy, followed by an in-depth panel conversation moderated by McCrary Institute Director Frank Cilluffo and an audience question-and-answer session. The panel will consist of Gorham; Tonya Ugoretz, FBI deputy assistant director; and Clyde Wallace, FBI

ring on `unsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

ector Matt Gorham will offer opening remarks on the new strategy, followed by an in-depth panel conversation moderated by McCrary Institute Director Frank Cilluffo and an audience question-and-answer session. The panel will consist of Gorham; Tonya Ugoretz, FBI deputy assistant director; and Clyde Wallace, FBI

ng on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

ector Matt Gorham will offer opening remarks on the new strategy, followed by an in-depth panel conversation moderated by McCrary Institute Director Frank Cilluffo and an audience question-and-answer session. The panel will consist of Gorham; Tonya Ugoretz, FBI deputy assistant director; and Clyde Wallace, FBI